文献速递慢阻肺

实时呼气分析揭示慢阻肺急性加重的特异性代谢特征

Real-Time Breath Analysis Reveals Specific Metabolic Signatures of COPD Exacerbations.
PubMed 文献 · Chest · 2019-01-24

这项匹配队列研究用实时次级电喷雾电离高分辨质谱分析稳定期慢阻肺患者呼气挥发性有机化合物,比较26例频繁加重者与26例非频繁加重者。频繁加重者ω-氧化通路代谢物(ω-羟基、ω-氧代和二羧酸)持续降低,多种硝基芳香族代谢物显著升高。提示呼气代谢谱可反映加重风险相关的生化过程。

要点

  • 频繁加重者(过去12个月≥2次加重)呼气中ω-氧化通路代谢物持续降低。
  • 频繁加重者呼气中多种硝基芳香族代谢物显著升高。
  • 实时次级电喷雾高分辨质谱可用于慢阻肺呼气代谢谱分析。

核心结论

  • 慢阻肺频繁加重者存在特定的呼气代谢特征,涉及ω-氧化通路下调及硝基芳香族代谢物升高。

研究设计与样本

  • 匹配队列研究,纳入26例频繁加重者和26例非频繁加重者,按年龄、性别和吸烟史匹配,在无加重间期采集呼气。
  • 采用实时次级电喷雾电离高分辨质谱分析呼气挥发性有机化合物,用Wilcoxon秩和检验识别显著变化的代谢物。

主要发现

  • ω-氧化通路的ω-羟基、ω-氧代和二羧酸类代谢物水平在频繁加重者中持续降低。
  • 多种硝基芳香族代谢物在频繁加重者中显著升高。

临床怎么用

  • 呼气代谢谱有望用于识别有未来加重风险的慢阻肺患者,辅助治疗优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Exacerbations of COPD are defined by acute worsening of respiratory symptoms leading to a change in therapy. Identifying altered metabolic processes in patients at risk for future exacerbations is desirable for treatment optimization, the development of new therapeutic strategies, and perhaps diagnostic value. We aimed to identify affected pathways using the profiles of volatile organic compounds in exhaled breath from patients with COPD with and without frequent exacerbations (≥ 2 exacerbations within the past 12 months). METHODS: In this matched cohort study, exhaled breath profiles from patients with COPD and frequent exacerbations ("frequent exacerbators") and without frequent exacerbations ("nonfrequent exacerbators") were analyzed during an exacerbation-free interval using real-time secondary electrospray ionization high-resolution mass spectrometry. We analyzed exhaled breath from 26 frequent exacerbators and 26 nonfrequent exacerbators that were matched in terms of age, sex, and smoking history. To obtain new pathophysiological insights, we investigated significantly altered metabolites, which can be assigned to specific pathways. Metabolites were identified by using a Wilcoxon rank-sum test. RESULTS: Metabolite levels from the ω-oxidation pathway, namely ω-hydroxy, ω-oxo, and dicarboxylic acids, were consistently decreased in frequent exacerbators. Additionally, several new nitro-aromatic metabolites, which were significantly increased in frequent exacerbators, were identified. CONCLUSIONS: Real-time breath analysis by secondary electrospray high-resolution mass spectrometry allows molecular profiling of exhaled breath, providing insights about ongoing biochemical processes in patients with COPD at risk for exacerbations. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT02186639; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Gaugg MT, Nussbaumer-Ochsner Y, Bregy L, et al. Real-Time Breath Analysis Reveals Specific Metabolic Signatures of COPD Exacerbations. Chest. 2019. PMID: 30685334. doi:10.1016/j.chest.2018.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。